News for Sanofi SA (SNW2.MU)

Players in the microneedle drug delivery system market are leveraging growing demand for minimally invasive, pain-free therapeutic options for infectious and

The president said enough vaccines would be available two months earlier than he had previously indicated, after Merck agreed to help Johnson & Johnson produce shots.

By Sabrina Siddiqui and Tarini Parti Merck & Co. will help produce Johnson & Johnson's single-dose Covid-19 vaccine, President Biden plans to announce Tuesday, as the administration... | March 2, 2021

The president said enough vaccines would be available two months earlier than he had previously indicated, after Merck agreed to help Johnson & Johnson produce shots.

Generic injectable drugs are those which have same active ingredient as innovator drug and is equivalent to its innovator drug in dosage form, safety,

American Finance Trust Inc (NASDAQ:AFIN) is an undervalued, high-dividend REIT with a strong balance sheet and exceptional acquisition strategy.

Eli Lilly And Co (NYSE: LLY) announced a licensing deal Thursday with smaller biopharma Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) that helps Lilly ...

Bristol-Myers Squibb Co (NYSE: BMY) and Sanofi SA (NASDAQ: SNY) were ordered to pay the state of Hawaii more than $834 ...

U.S. stock futures rose Tuesday, adding to Friday's record closes for the Dow, S&P 500 and Nasdaq.

The stocks making the biggest moves in premarket trading include Palantir, MicroStrategy, CoreLogic, and more.

Bristol-Myers Squibb Co. and Sanofi SA were ordered to pay more than $834 million to the state of Hawaii for failing to issue proper warning of health risks to consumers from its blood thinner Plavix.

Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap earnings, m...

Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap earnings, multiple ...

Sanofi SA (NASDAQ: SNY) has launched a takeover offer for Kiadis Pharma NV (OTC: KIADF) to represent an aggregate adjusted ...

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

European stocks are heading for a modestly higher open Friday as investors look to vaccine rollouts for hopes of normalization following the Covid-19 pandemic.

Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of innovation among ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) ...

TORONTO, Jan. 25, 2021 /CNW/ - Corporate Knights 17th annual ranking of the world's 100 most sustainable corporations is being released this morni...